Meet the GenEdit Leadership

GenEdit was founded by UC Berkeley scientists who developed targeted delivery technologies for CRISPR therapeutics. The GenEdit founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases. 


Kunwoo Lee,

Ph.D. UC Berkeley

CEO and Co-founder

Hyo Min Park,

Ph.D. UC Berkeley

CTO and Co-founder



George Church, Ph.D.

Scientific advisory board
Professor, Harvard

Matthew Rabinowitz, Ph.D.

Advisory board
CEO, Natera, Inc.

Steve Lo

Business development advisor 
CCO, Puma Biotechnology

Stephanie Marrus

Operation advisor 
Director, Entrepreneurship center at UCSF